Entero Therapeutics, Inc. Quarterly Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent in pure from Q1 2023 to Q1 2025
-
Taxonomy & unit
-
us-gaap: pure
-
Description
-
Percentage of domestic federal statutory tax rate applicable to pretax income (loss).
-
Summary
-
Entero Therapeutics, Inc. quarterly/annual Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent history and growth rate from Q1 2023 to Q1 2025.
- Entero Therapeutics, Inc. Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for the quarter ending March 31, 2025 was 0 pure, a 100% decline year-over-year.
- Entero Therapeutics, Inc. annual Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for 2024 was 0.21 pure, unchanged from 2023.
- Entero Therapeutics, Inc. annual Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for 2023 was 0.21 pure, unchanged from 2022.
- Entero Therapeutics, Inc. annual Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for 2022 was 0.21 pure, unchanged from 2021.
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent, Quarterly (pure)
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent, YoY Quarterly Growth (%)